Menu
Search
|

Menu

Close
X

IQVIA Holdings Inc IQV.N (New York Stock Exchange)

151.35 USD
+0.62 (+0.41%)
As of Sep 13
Previous Close 150.73
Open 149.00
Volume 474,041
3m Avg Volume 299,554
Today’s High 152.47
Today’s Low 148.99
52 Week High 164.05
52 Week Low 104.91
Shares Outstanding (mil) 215.11
Market Capitalization (mil) 20,585.61
Forward P/E 131.73
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.74 Mean rating from 19 analysts

KEY STATS

Revenue (mm, USD)
FY19
5,424
FY18
10,412
FY17
9,702
FY16
6,878
EPS (USD)
FY19
0.587
FY18
1.075
FY17
1.392
FY16
1.666
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
131.73
32.66
Price to Sales (TTM)
vs sector
2.41
7.91
Price to Book (MRQ)
vs sector
2.75
5.38
Price to Cash Flow (TTM)
vs sector
26.16
24.36
Total Debt to Equity (MRQ)
vs sector
118.74
14.55
LT Debt to Equity (MRQ)
vs sector
117.50
10.20
Return on Investment (TTM)
vs sector
0.80
14.48
Return on Equity (TTM)
vs sector
1.99
15.78

EXECUTIVE LEADERSHIP

Ari Bousbib
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $1,600,000.00
Bonus: --
Michael McDonnell
Chief Financial Officer, Executive Vice President, Since 2015
Salary: $650,000.00
Bonus: --
Kevin Knightly
President - Information and Technology Solutions, Since 2016
Salary: $517,500.00
Bonus: --
Walter Staub
President - Research and Development Solutions, Since 2016
Salary: $578,550.00
Bonus: --
Eric Sherbet
Executive Vice President, General Counsel, Secretary, Since 2018
Salary: $415,833.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

4820 Emperor Blvd
DURHAM   NC   27703-8426

Phone: +1919.9982000

IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.

SPONSORED STORIES